Related Experiment Video

Updated: Jul 2, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Survival in lung cancer

D J Rickles1, R G Parker, D J Demanes

  • 1Division of Radiation Oncology, University of California, Los Angeles, Center for the Health Sciences.

The Western Journal of Medicine
|January 1, 1978
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Experiment Videos

Last Updated: Jul 2, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Articles linked to this work by shared authors, journal, and citation graph.

Aerosol particle analyzer.

Applied optics·2010

Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil.

AIDS care·2007

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.

International journal of radiation oncology, biology, physics·2001

High-grade carcinoma of the prostate: a comparison of current local therapies.

Urology·2001

Radiation oncology: contributions of the United States in the last years of the 20th century.

Radiology·2001

High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2000

Analysis of questions asked by family physicians regarding patient care.

The Western journal of medicine·2008

Clinical characteristics and prognostic factors associated with recurrence in periocular basal cell carcinoma in a Taiwanese population.

Japanese journal of ophthalmology·2026

Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026

The impact of menopausal status on the efficacy of adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: a systematic review and meta-analysis of phase III clinical trials.

Breast cancer research and treatment·2026

DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression.

Molecular biology reports·2026

Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center.

World journal of urology·2026

Integrated Phytochemical, Computational and In Vitro Evaluation of the Oocysticidal Activity of Pleurotus ostreatus Extract Against Cryptosporidium parvum.

Cell biochemistry and biophysics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us